Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $343.3000 (2.5%) ($333.9500 - $345.8500) on Fri. Mar. 16, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.07% (three month average) | | RSI | 68 | | Latest Price | $343.3000(2.5%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | | Weekly Trend | REGN advances 2.4% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Value stock rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | | Factors Impacting REGN price | REGN will decline at least -1.035% in a week (0% probabilities).
UUP(-10%) VIXM(-6%) TLT(-6%) TIP(-1%) SHY(-1%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.035% (StdDev 2.07%) | | Hourly BBV | 0 () | | Intraday Trend | 2% | | | | | |
|
| 5 Day Moving Average | $340.39(0.85%) | | 10 Day Moving Average | $338.76(1.34%) | | 20 Day Moving Average | $331.32(3.62%) | | To recent high | -12.8% | | To recent low | 8.7% | | Market Cap | $36.4b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |